ENDRA Life Sciences Inc. announced impairment charges for the first quarter ended March 31, 2024. For the period, the company announced fixed assets write off of $8,808.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.269 USD | -3.96% | -4.68% | -87.31% |
14/05 | Transcript : ENDRA Life Sciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.31% | 30.91L | |
+43.36% | 5.81TCr | |
-5.31% | 4.05TCr | |
+37.52% | 3.9TCr | |
+14.75% | 2.67TCr | |
-12.56% | 2.66TCr | |
-22.45% | 1.9TCr | |
+0.04% | 1.22TCr | |
+25.12% | 1.2TCr | |
+26.04% | 1.19TCr |
- Stock Market
- Equities
- NDRA Stock
- News ENDRA Life Sciences Inc.
- Endra Life Sciences Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024